Clinical trial
Lenticule Implantation and Autologous Serum New Approach in Treatment of Adenoviral Keratitis Disease
NCT05123014 is registered in ClinicalTrials.gov with Eye Hospital Pristina Kosovo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lenticule Implantation and Autologous Serum New Approach in Treatment of Adenoviral Keratitis Disease
- Lead sponsor
- Eye Hospital Pristina Kosovo
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- February 1, 2018
- Completion date
- February 1, 2027
- Enrollment
- 45 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adenoviral keratoconjunctivitis